New measures to ease the pressure in pharmacies
We've responded to new measuresto cut bureaucracy and help ease immediate pressures on community pharmacies.
Commenting on the Covid booster programme and today’s announcement from the PSNC (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 15, 2021 Category: Drugs & Pharmacology Source Type: news
Understanding the impact of Gender Microaggressions
We’ve created a guide to gender microaggressions with volunteers from our Action in Belonging Culture and Diversity (ABCD) group, as part of our work on inclusion and diversity.
Gender related (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 15, 2021 Category: Drugs & Pharmacology Source Type: news
COVID-19 Therapeutic Alert
Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19
In parallel to the publication of revised guidance from the National Institute for Health a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 15, 2021 Category: Drugs & Pharmacology Source Type: news
NHS England COVID-19 letters
NHS England has issued three letters.
Letter 1: Preparing the NHS for the potential impact of the Omicron Variant and other winter pressures
This letter sets out important actions that NHS Englan (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 15, 2021 Category: Drugs & Pharmacology Source Type: news
Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person
The UK Health Security Agency has issued updated guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person
Anyone aged 5 years and over, who ha (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 14, 2021 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre-filled syringe
Novartis Pharmaceuticals UK are recalling a specified batch of Lucentis 10 mg/ml solution for injection in pre-filled syringe due to a faulty plunger stopper which has led to an increased number of cu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 13, 2021 Category: Drugs & Pharmacology Source Type: news
RPS responds to further booster rollout
Following on from the Prime Minister’s announcement yesterday that booster jabs will be offered to everyone over 18 in England from this week, Thorrun Govind, Chair of RPS in England said:&ldqu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 13, 2021 Category: Drugs & Pharmacology Source Type: news
We support further Covid booster rollout
Following on from the Prime Minister’s announcement yesterday that booster jabs will be offered to everyone over 18 in England from this week, Thorrun Govind, Chair of RPS in England said:&ldqu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 13, 2021 Category: Drugs & Pharmacology Source Type: news
